340B Program HRSA Response to Pharmaceutical Manufacturers

After months of pharmaceutical manufacturers placing restrictions on the 340B Program to both contract pharmacies and covered entities, HRSA sent letters to six pharmaceutical manufacturers stating they violated the 340B […]
Read More